SUMO3 modification accelerates the aggregation of ALS-linked SOD1 mutants.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24971881.
- Also identified by DOI 10.1371/journal.pone.0101080 and PMC identifier 4074151.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mutations in superoxide dismutase 1 (SOD1) are a major cause of familial amyotrophic lateral sclerosis (ALS), whereby the mutant proteins misfold and aggregate to form intracellular inclusions. We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS. In these cells, SUMO1 modification occurred on both lysine 75 and lysine 9 of SOD1, and modification of ALS-linked SOD1 mutant proteins by SUMO3, rather than by SUMO1, significantly increased the stability of the proteins and accelerated intracellular aggregate formation. These findings suggest the contribution of sumoylation, particularly by SUMO3, to the protein aggregation process underlying the pathogenesis of ALS.
Medical subject headings
- Amyotrophic Lateral Sclerosis
- Mutation
- Protein Aggregation, Pathological
- Superoxide Dismutase
- Ubiquitins